Whalesbook
Smruthi Organics Ltd announced on May 13, 2026, that its Board of Directors approved several key decisions. The board recommended a dividend of ₹1.5 per equity share, equivalent to 15% of the ₹10 face value, for the financial year 2025-26. The company also scheduled its 37th Annual General Meeting (AGM) for August 10, 2026. To ensure smooth processing for the dividend and AGM, the company's books will close from August 1 to August 10, 2026. The record date for determining which shareholders are eligible for the dividend is July 31, 2026.
This announcement gives shareholders clarity on their expected returns for FY26. It also sets the timeline for the company's main governance event, the AGM, where key decisions are made.
Smruthi Organics has a history of returning profits to shareholders. For FY 2023-24, the company recommended a 10% dividend (₹1.0 per share). In FY 2022-23, the board proposed a 15% payout (₹1.5 per equity share), similar to the current recommendation.
Shareholders can expect a dividend of ₹1.5 per share, pending approval at the AGM. The AGM on August 10, 2026, is a key event for shareholders to vote on company matters, including the dividend. The book closure period ensures only shareholders registered by the record date will receive the dividend.
The main risk is that the recommended dividend requires final shareholder approval at the AGM. Adverse resolutions or shareholder dissent could potentially affect the payout.
Smruthi Organics operates in the competitive Active Pharmaceutical Ingredients (API) sector, alongside companies like Divi's Laboratories, Laurus Labs, Granules India, and Aarti Drugs. Dividend policies often vary among these companies depending on their growth and cash flow needs.
Investors will be watching for the outcome of the AGM on August 10, 2026. Other key points to track include the official dividend declaration and payment date, as well as any management commentary on future performance during the AGM.